M
Meacor
Health Tech & Medtech · Ayer, United States · Founded 2015
Developing novel minimally invasive medical devices MoreLess
Meacor is a medical device company that specializes in the development of minimally invasive solutions for heart valve repair. The company is focused on creating transcatheter interventions for valvular disease, with its flagship technology being the CryoCinch system.
Recently, Meacor has secured a significant capital infusion of $15 million through a Series A funding round. This financing is intended to advance the development and commercialization of its heart valve repair technology. The company serves the medical community, specifically targeting cardiologists and surgeons who perform heart valve procedures. Its business model revolves around the research, development, and subsequent sale of its proprietary medical devices to hospitals and clinics. The primary market is the cardiovascular device sector, a field with a continuous demand for less invasive treatment options.
Keywords: medical devices, cardiovascular, transcatheter, heart valve repair, CryoCinch system, minimally invasive, valvular disease, medtech, cardiology, healthcare
Company overview
Meacor company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Ayer, United States
- Employees
- 8
- Open positions
- 1
- Dealroom signal
- 82.7
Valuation & funding
Meacor funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $15M | $60M | Undisclosed | ↗ |
| OtherOther financing | Jun 2022 | $0 | — | MedTech Innovator | ↗ |
| ANGELEquity / VC | Jan 2018 | $380K | $1.5M | Im Capital · Kafalat | — |
| SPINOUT✓Other financing | Jan 2015 | $0 | — | McGill University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 8 |
| 2025 | 4 |
| 2024 | 3 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 4 |
| 2020 | 2 |
Growth signals
Meacor website traffic
Latest recorded traffic for Meacor is 440 monthly website visits, down 79% over the last three months. Meacor's team grew 100% over the past year.
Hiring
Open positions at Meacor
Current openings linked to this company in Dealroom.
Comparisons
Meacor compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Meacor's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Meacor's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Meacor has talent and traffic
team presence
In the news
Latest news about Meacor
Recent press, funding announcements, and product moves mentioning Meacor — open to read from the original sources.
Market sentiment
What the market is saying about Meacor
An AI-synthesized read of the highest-engagement posts about Meacor on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Meacor’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.